Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant CAPOX chemotherapy in stage III colon carcinoma in patients aged ≥70 years
2006-000267-29Phase 2Completed
- Sponsor
- Centro Sociale Oncologico
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin and capecitabine in colon cancer, sponsored by Centro Sociale Oncologico. Primary endpoints: Dose intensity and Type and seriousness of side effects. Started Apr 2006; status: completed.
02
Drugs
oxaliplatincapecitabine
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2006-000267-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000267-29.